IM Cannabis Corp. Files Q2 2025 Financials

Ticker: IMCC · Form: 6-K · Filed: 2025-08-12T00:00:00.000Z

Sentiment: neutral

Topics: financials, foreign-private-issuer, reporting

TL;DR

IM Cannabis Corp. dropped its Q2 2025 financials, check the numbers.

AI Summary

IM Cannabis Corp. filed a Form 6-K on August 12, 2025, reporting its unaudited interim condensed consolidated financial statements for the three and six months ended June 30, 2025. The filing also includes Management's Discussion and Analysis of Financial Condition and Results of Operations. The company is incorporated in Israel and its principal executive offices are located in Kibbutz Glil Yam.

Why It Matters

This filing provides investors with the latest financial performance data for IM Cannabis Corp., crucial for understanding the company's operational health and future prospects in the medicinal and botanical products sector.

Risk Assessment

Risk Level: medium — As a foreign private issuer in the cannabis sector, IM Cannabis Corp. faces regulatory, market, and operational risks that could impact its financial performance.

Key Numbers

Key Players & Entities

FAQ

What specific financial results are detailed in the unaudited interim condensed consolidated financial statements?

The filing states that the unaudited interim condensed consolidated financial statements for the three and six months ended June 30, 2025 are attached as Exhibit 99.2, but the specific results are not detailed within the provided text.

What is the filing type and its purpose?

The filing is a Form 6-K, which is a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934, used to report material information to the SEC.

When was this Form 6-K filed with the SEC?

This Form 6-K was filed on August 12, 2025.

What is the fiscal year end for IM Cannabis Corp.?

The fiscal year end for IM Cannabis Corp. is December 31.

Does IM Cannabis Corp. file annual reports under Form 20-F or Form 40-F?

IM Cannabis Corp. indicates it files annual reports under Form 20-F.

From the Filing

0001178913-25-002780.txt : 20250812 0001178913-25-002780.hdr.sgml : 20250812 20250812081525 ACCESSION NUMBER: 0001178913-25-002780 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 61 CONFORMED PERIOD OF REPORT: 20250630 FILED AS OF DATE: 20250812 DATE AS OF CHANGE: 20250812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IM Cannabis Corp. CENTRAL INDEX KEY: 0001792030 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40065 FILM NUMBER: 251204154 BUSINESS ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 BUSINESS PHONE: 416-256-4202 MAIL ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 6-K 1 zk2533558.htm 6-K IM Cannabis Corp. - 1792030 - 2025 false Q2 0001792030 --12-31 2025-06-30   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     Form 6-K     REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16   UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of August 2025 .   Commission File Number: 001-40065   IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter)     Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executive offices)   Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.   Form 20-F ☒  Form 40-F ☐     CONTENTS   This Report of Foreign Private Issuer on Form 6-K consists of IM Cannabis Corp.’s (the “Company”): (i) Unaudited Interim Condensed Consolidated Financial Statements for the three and six months ended June 30, 2025, which are attached hereto as Exhibit 99.2; and (ii) Management’s Discussion and Analysis of Financial Condition and Results of Operations for the three and six months ended June 30, 2025, which is attached hereto as Exhibit 99.3.   This Report of Foreign Private Issuer on Form 6-K (this “Form 6-K”), excluding the section titled “Management Commentary” of Exhibit 99.1, Exhibit 99.4 and Exhibit 99.5 hereto, is incorporated by reference into the Company’s Registration Statement on Form F-3 (File No.  333-288346 ) filed with the Securities and Exchange Commission to be a part thereof from the date on which this Report of Foreign Private Issuer on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.   SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.     IM CANNABIS CORP.   (Registrant)       Date: August 12, 2025 By: /s/ Oren Shuster   Name:    Oren Shuster   Title: Chief Executive Officer and Director     EXHIBIT INDEX   99.1 News Release dated August 12, 2025 99.2 Interim Consolidated Financial Statements for the three and six months ended June 3o, 2025 99.3 Management's Discussion and Analysis for the three and six months ended June 30, 2025 99.4 Certification of Interim Filings by CFO dated August 12, 2025 99.5 Certification of Interim Filings by CEO dated August 12, 2025   EX-99.1 2 exhibit_99-1.htm EXHIBIT 99.1 Exhibit 99.1 IM Cannabis Reports Second Quarter 2025 Financial Results   IMC Delivers Strong Profit and Margin Growth Despite Revenue Impact from External Challenges in Q2 2025   TORONTO and GLIL YAM, Israel, August 12, 2025 /PRNewswire/ -- IM Cannabis Corp. (the " Company " or " IMC ") (NASDAQ: IMCC), an international medical cannabis company, announced its financial results today for the second quarter ende

View on Read The Filing